Ajay J Kirtane, MD, SM
March 29th, 2014
TAVR: Are You Impressed Now?
Ajay J Kirtane, MD, SM
Interventionalist Ajay Kirtane offers his perspective on the new randomized trial comparing transcatheter (CoreValve) with surgical aortic valve replacement.
August 19th, 2013
Look Before Leaping to Conclusions About Bush’s Stent
Ajay J Kirtane, MD, SM
Ajay Kirtane shares his thoughts on the publicity surrounding Bush’s stent and what it means for the public perception of PCI.
January 16th, 2013
“Nostalgic Professionalism” or Actually Caring About Patients?
Ajay J Kirtane, MD, SM
Is caring about your patients when you’re not on duty becoming unacceptable?
October 4th, 2012
Beta-Blockers May Not Work as Well as We Thought: So What Does “Optimal Medical Therapy” Really Mean?
Ajay J Kirtane, MD, SM
Proponents of optical medical therapy believe that the benefits of coronary revasculartion in stable ischemic disease were established in outdated studies. But if beta blockers aren’t very effective, is optimal therapy just aspirin and a statin?
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?